Evidences that SARS-CoV-2 Vaccine-Induced apoplexy may not be solely due to ASIA or VITT syndrome', Commentary on Pituitary apoplexy and COVID-19 vaccination: A case report and literature review

Front Endocrinol (Lausanne). 2023 Jan 25:14:1111581. doi: 10.3389/fendo.2023.1111581. eCollection 2023.

Authors

Ach Taieb^{1

2

3}, Ben Abdelkrim Asma^{1

2}, El Euch Mounira⁴

Affiliations

¹ Department of Endocrinology, University Hospital of Farhat Hached, Sousse, Tunisia.
² University of Sousse, Faculty of Medicine of Sousse, Sousse, Tunisia.
³ Laboratory of Exercise Physiology and Pathophysiology, University Hospital of Farhat Hached, Sousse, Tunisia.
⁴ Department of Internal Medicine, University Hospital of Charles Nicolle, Tunis, Tunisia.

No abstract available

Keywords: COVID-19; SARS-CoV-2; apoplexy; hypophysitis; pituitary adenoma; vaccine.

Publication types

Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / complications
Humans
Pituitary Apoplexy* / etiology
SARS-CoV-2
Stroke* / complications
Syndrome
Vaccination / adverse effects

Substances

COVID-19 Vaccines